Skip to main content
Fig. 6 | Lipids in Health and Disease

Fig. 6

From: 4-cholesten-3-one decreases breast cancer cell viability and alters membrane raft-localized EGFR expression by reducing lipogenesis and enhancing LXR-dependent cholesterol transporters

Fig. 6

Cell viability of MCF-7 and MDA-MB-231 breast cancer cells after exposure to 4-cholesten-3-one. Cells were treated with the indicated concentrations of 4-cholesten-3-one for 24 and 48 h, and the cell viability was determined by MTT assay. The data are represented as mean ± standard deviation. Statistical analysis was performed using t-test, * denote p < 0.05, ** p < 0.01, *** p < 0.001

Back to article page